Where I see patients (2)
My reviews
Selected research
-
Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity.
Cancers
-
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN
-
Flashback Foreword: KRAS Is a Selection Marker for Panitumumab Benefit in Patients With Metastatic Colorectal Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Clinical trials
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Can...
Overall survival is defined as the time from randomization to death due to any cause. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator. The treatment arms will be compared using a stratified C...
Recruiting
4.9